Eledon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $560 | $0 | $0 |
Gross Profit | -97 | -95 | -94 |
EBITDA | -14,405 | -10,774 | -10,244 |
EBIT | -14,502 | -10,817 | -10,287 |
Net Income | -44,907 | -10,295 | -9,626 |
Net Change In Cash | 560 | 0 | 0 |
Free Cash Flow | -7,774 | -8,741 | -9,131 |
Cash | 26,039 | 5,655 | 4,612 |
Basic Shares | 42,278 | 29,989 | 24,213 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $120 | $120 |
Gross Profit | -374 | -373 | 120 | -63 |
EBITDA | -42,626 | -87,593 | -36,672 | -23,032 |
EBIT | -43,000 | -87,966 | -36,867 | -23,215 |
Net Income | -40,326 | -87,504 | -34,506 | -22,811 |
Net Change In Cash | 0 | 0 | 120 | 120 |
Free Cash Flow | -39,527 | -28,424 | -28,913 | -15,212 |
Cash | 4,612 | 56,409 | 84,833 | 114,195 |
Basic Shares | 24,619 | 14,285 | 14,819 | 1,451 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.32 |
2024-06-30 | -$1.06 |
2024-03-31 | -$0.34 |
2023-12-31 | -$0.29 |
